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Introduction
Thyroid hormones (3,5,3'-triiodothyronine; T3
and thyroxine; T4) play an important role in the regu-
lation of cell metabolism. The biological function of T3
is mediated through thyroid hormone receptors (TRs),
which bind to specific DNA segments (thyroid hormo-
ne response elements, TREs) in the regulatory regions
of target genes, thus altering gene expression (1). Sub-
sequently, thyroid hormone deficiency is characterized
by major metabolic disturbancies, including lipid me-
tabolism. 
The impact of thyroid hormones on lipid levels is
primarily mediated through activation of promoter re-
gions of the low-density lipoprotein (LDL) receptor, 3-
-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) re-
ductase, cholesteryl-ester transfer protein (CETP) and
hepatic lipase (HL) genes (2’5). Hypothyroidism is a
well-established cause of secondary dyslipidaemia and
the increased risk of atherosclerosis (6). It is charac-
terized by hypercholesterolaemia and a marked incre-
ase of LDL. This is caused by a markedly decreased
fractional clearance of LDL particles because of a re-
duced number of LDL receptors in the liver. However,
conflicting results were obtained in different studies
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Summary: Hypothyroidism is associated with dislipidaemia and an increased risk of atherosclerosis. The
aim of this study was to examine the effect of disease and long-term levothyroxine replacement therapy on serum
lipids in hypothyroid children. We measured concentrations of total cholesterol, HDL-cholesterol, LDL-choles-
terol, triglycerides and thyroid-stimulating hormone in serum samples of 58 children with hypothyroidism (before
and after therapy) and in 100 healthy controls. LDL-C and TC values were most markedly affected by the hypothy-
roid state. The values in the patients were on the average of 100% (LDL-C) and 54% (TC) higher than in the
healthy controls. This finding is accordance with the known fact that LDL clearance is slower in hypothyroidism.
TG concentrations were slightly higher (p<0.05) and HDL-C lower (p<0.02), but only in some age groups of
patients. The effect of long-term L-T4 replacement on LDL-C and TC was quantitatively most pronounced. The
values obtained in patients after therapy were markedly lower than before therapy and did not differ significantly
from the values found in the corresponding age groups of healthy children. Significantly lower concentrations of
HDL-C and TG after L-T4 administration were found only in children aged from 10 to 15 years. When  we com-
pared the lipid-lowering effect of L-T4 replacement therapy in normometabolic versus hypometabolic patients, we
obtained a significantly greater effect on TC and LDL-C values in the normometabolic than in hypometabolic
group (p<0.01). TC and LDL-C concentrations obtained in the L-T4 treated patients correlated well with the cor-
responding TSH levels (r = 0.770 and 0.725, respectively).
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concerning HDL-C levels in hypothyroidism: HDL-C
was reported to be normal (7), increased (8’10) or
decreased (11). 
The influence of different genetic and environ-
mental factors is very important in the regulation of
lipid and lipoprotein metabolism. Therefore, studies
investigating normal or pathological lipid metabolism
have to be conducted in different populations. In the
present study, we investigated the effect of disease and
long-term L-T4 replacement therapy on serum lipid
profile in hypothyroid children from Montenegro. Se-
rum concentrations of total cholesterol (TC), HDL-
-cholesterol (HDL-C), LDL-cholesterol (LDL-C) and
triglycerides (TG) were measured in the patients before
and after L-T4 replacement. The same data sets were
obtained for a group of 100 healthy children, matched
according to age and gender. We also compared the
extent of the L-T4 effect on serum lipids found in pa-
tients divided according to their metabolic status and
TSH levels. 
Materials and Methods
Study population
Serum lipid profile was assessed in a population
of 58 hypothyroid children (22 boys and 36 girls),
attending the Institute of Children’s Diseases, Clinical
Centre of Podgorica. The patients were aged from 2
months to 18 years, since the age at which clinically
overt hypothyroidism appeared depended on the se-
verity of the defect. Analyses were performed on two
occasions: (1) when diagnosis of hypothyroidism was
established and (2) at follow-up examination, after
long-term L-T4 replacement therapy. The control gro-
up consisted of 100 healthy children, matched
according to age and gender.
Metabolic status of hypothyroid children was as-
sessed by endocrinologist at follow-up examination,
based on characteristic clinical signs and symptoms,
and the patients were thus classified as normo-, hypo-
or hypermetabolic. 
Reagents and Procedures
Serum lipid profile analyses were carried out in
blood samples collected after a 12-h fasting period.
Serum was separated by centrifugation at 3000 rpm
and fresh samples were analyzed. TC and TG were
measured by standard enzymatic methods, using co-
mmercial reagent kits from Randox Laboratories Ltd.
(Crumlin, United Kingdom). HDL-C was assayed by
the same enzymatic method used for the TC meas-
urement, after precipitation with phosphotungstic acid
in the presence of magnesium ions. The concentra-
tion of LDL-C was calculated with the Friedewald’s for-
mula (12). TSH levels were measured by time-resolved
fluoroimmunoassay by DELFIAÛ hTSH reagent kit
from Wallac Oy (Turku, Finland).
Statistical Methods
All values were expressed as means ± SD. The
patients and healthy controls were divided in five age
groups. Comparison of serum lipid values between
patients and control subjects, as well as between the
values obtained in patient groups before and after
therapy, was performed by Student’s t-test. The signi-
ficance of the difference between the lipid concentra-
tions found in individual patients before and after L-T4
replacement was assessed by using the paired Student
t-test. The concentrations of serum lipids in the treat-
ed patients were also correlated with the correspon-
ding TSH levels by linear regression analysis.
Results
The concentrations of serum lipids obtained in
children with hypothyroidism before and during long-
term L-T4 replacement therapy as well as in healthy
controls are shown in Table I. The LDL-C and TC va-
lues were most markedly affected by hypothyroid sta-
te: the values in the patients were on the average of
100% (LDL-C) and 54% (TC) higher than in the he-
althy children. TG concentrations were slightly higher
(p<0.05) and HDL-C lower (p<0.02), but only in so-
me age groups. 
The effect of long-term L-T4 replacement on LDL-
-C and TC was quantitatively most pronounced: the
values obtained in patients after therapy were mar-
kedly lower than before therapy and did not differ sig-
nificantly from the values found in the corresponding
age groups of healthy children. Lower concentrations
of HDL-C were obtained after L-T4 replacement, but
the differences between the values found before and
after therapy were statistically significant only in chil-
dren aged from 10 to 15 years (p<0.05). In the same
age group of patients, replacement therapy induced
a significant decrease of serum TG concentrations
(p<0.005).
In order to compare the lipid-lowering effect of
long-term L-T4 replacement therapy in normometa-
bolic versus hypometabolic patients, the concentra-
tions of serum lipids in patients under long-term ther-
apy were expressed as percents of the respective base-
line values before therapy (Table II). Marked effect of
L-T4 administration of serum TC and LDL-C levels
were found not only in normometabolic, but also in
hypometabolic patients. However, significantly greater
effect on TC and LDL-C values was found in the nor-
mometabolic than in hypometabolic group (p<0.01).
The decrease in HDL-C levels induced by long-term L-
-T4 administration was significant in both groups of
patients (p<0.01). The drug effects mentioned above
can be most clearly seen from data presented in
Figure 1, where the individual TC, HDL-C, LDL-C and
TG levels obtained in the same patients before and
after therapy, are shown.
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We assessed the correlation between the concen-
trations of the measured serum lipid profile parameters
and the corresponding TSH levels in hypothyroid chil-
dren receiving long-term L-T4 therapy. Good correla-
tion was obtained between the TC and TSH values (y
= 3.282 + 0.162x; r = 0.770; Figure 2), as well as bet-
ween the LDL-C and TSH (y=1.689+0.149x; r=0.725)
values. When the correlations of HDL-C vs. TSH and
TG vs. TSH were tested, low correlation coefficients
were obtained (r= ’0.122 and r = 0.399, respectively).
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Cholesterol
Triglycerides
HDL-cholesterol
LDL-cholesterol
Normometabolic
(N = 35)
%
62.1
97.8
91.0
50.3
p
<0.01
n.s.
<0.01
<0.01
%
94.9
130.2
87.9
80.0
p
<0.01
n.s.
<0.01
<0.01
Hypometabolic
(N=17)
p
(normo vs. 
hypometabolic)
<0.01
n.s.
n.s.
<0.01
Table II   Comparison of lipid-lowering effect of L-T4 replacement therapy in normometabolic versus 
hypometabolic patients. The concentrations of serum lipids in patients under long-term therapy 
are shown as percents of the respective baseline values before therapy (n.s. - not significant)
Age
(years)
0.1’1
1.1’5
5.1’10
10.1’15
15.1’18
0.1’1
1.1’5
5.1’10
10.1’15
15.1’18
0.1’1
1.1’5
5.1’10
10.1’15
15.1’18
0.1’1
1.1’5
5.1’10
10.1’15
15.1’18
NI
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
I
(x “ SD)
3.12“0.48
3.74“0.67
3.77“0.48
3.92“0.57
3.99“0.53
0.76“0.37
0.67“0.24
0.78“0.33
0.98“0.54
0.82“0.19
1.37“0.38
1.36“0.26
1.39“0.36
1.46“0.33
1.49“0.30
1.40“0.65
2.08“0.73
2.02“0.51
2.02“0.38
2.12“0.54
NII
17
14
8
13
6
17
14
8
13
6
17
14
8
13
6
17
14
8
13
6
II
(x “ SD)
6.27“0.78
5.60“1.18
5.43“0.41
5.87“1.16
5.10“0.52
0.78“0.21
1.01“0.46
0.84“0.16
1.09“0.31
1.11“0.44
1.42“0.26
1.35“0.35
1.40“0.24
1.43“0.27
1.09“0.34
4.50“0.92
3.80“1.08
3.64“0.26
3.94“1.08
3.50“0.59
NIII
’
8
10
20
18
’
8
10
20
18
’
8
10
20
18
’
8
10
20
18
III
(x “ SD)
’
3.84“0.65
3.94“0.78
3.40“0.43
4.23“0.90
’
0.68“0.34
1.02“0.74
0.81“0.16
1.18“0.39
’
1.26“0.35
1.30“0.40
1.24“0.21
1.11“0.23
’
2.28“0.56
2.18“0.74
1.78“0.38
2.58“0.94
p
I’II
<0.001
<0.001
<0.001
<0.01
<0.01
n.s.
<0.05
n.s.
n.s.
<0.05
n.s.
n.s.
n.s.
n.s.
<0.02
<0.001
<0.001
<0.001
<0.001
<0.001
p
II’III
’
<0.001
<0.001
<0.001
<0.05
’
n.s.
n.s.
<0.005
n.s.
’
n.s.
n.s.
<0.05
n.s.
’
<0.005
<0.001
<0.001
<0.05
p
I’III
’
n.s.
n.s.
<0.01
n.s.
’
n.s.
n.s.
n.s.
<0.001
’
n.s.
n.s.
<0.02
<0.001
’
n.s.
n.s.
n.s.
n.s.
Table I   Concentrations of serum lipids in healthy children (I), children with hypothyroidism before therapy (II) 
and during long-term L-T4 replacement therapy (III) (n.s. - not significant)
CHOLESTEROL, mmol/L
TRIGLYCERIDES, mmol/L
HDL-CHOLESTEROL, mmol/L
LDL-CHOLESTEROL, mmol/L
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Figure 1.   Effect of long-term L-T4 replacement therapy on serum lipids in normometabolic and hypometabolic children
Discussion
Dyslipidaemia caused by thyroid hormone defi-
ciency is associated with the increased risk of athero-
sclerosis (6). Serum lipid profile in hypothyroidism is
characterized by hypercholesterolaemia with a marked
increase in LDL-cholesterol levels, but different results
were obtained in different studies concerning HDL-C
levels (7’11). 
The patients included in this study were aged
from 2 months to 18 years, since the age at which clin-
ically overt hypothyroidism appeared was dependent
on the severity of the disease. As serum lipid profile
change with age, TC, HDL-C, LDL-C and TG concen-
trations obtained in the patients before L-T4 adminis-
tration were compared with the corresponding values
found in the age-matched healthy controls (Table I).
TC and LDL-C values were most markedly affected by
hypothyroid state: the values in the patients were on
the average of 54% (TC) and 100% (LDL-C) higher
than in healthy children. In most patients, this increase
was sufficient to reach high-risk TC and LDL-C levels:
>5.15 mmol/L and >3.37 mmol/L, respectively (13). 
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Figure 2.   Correlation between serum TC and TSH levels (y=3.282 + 0.162x; r=0.770) and between LDL-C and TSH
(y=1.689 + 0.149x; r=0.725) in hypothyroid children receiving long-term L-T4 therapy
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The effect of the disease on serum TC and LDL-
-C concentrations was reversed by L-T4 treatment: the
values obtained in the treated patients were markedly
lower than the levels before L-T4 administration, and
did not differ significantly from the corresponding val-
ues found in healthy children (Table I). Our findings
agree with the results of other authors: hypercholes-
terolaemia and a marked increase of LDL-C are typi-
cally found in hypothyroid individuals (2, 6, 8, 9, 14). It
is well-known that the transcription of the HMG-CoA
reductase gene is activated by thyroid hormones
(2’5). As HMG-CoA reductase is the rate-limiting en-
zyme in the cholesterol synthesis pathway, lower cho-
lesterol synthesis rate is expected in hypothyroidism.
However, LDL-receptor gene is also one of the thyroid
hormone target genes. Although cholesterol synthesis
is impaired in hypothyroid state, this effect is over-
whelmed by a markedly decreased fractional clear-
ance of LDL particles because of a reduced number of
LDL receptors in the liver (2, 3). This leads to LDL
accumulation and high serum TC and LDL-C concen-
trations. Our finding that the cholesterol-lowering
effect of L-T4 replacement therapy was significantly
greater in normometabolic than in hypometabolic
patients (Table II, Figure 1) can also be explained in
terms of the mechanism described above: L-T4 admi-
nistration fully restored LDL-receptor synthesis in nor-
mometabolic, but uncompletely in hypometabolic pa-
tients. In normometabolic children, TC and LDL-C
concentrations after L-T4 replacement were in the ran-
ge of recommended values (Figure 1) : <4.4 mmol/L
and <2.85 mmol/L, respectively (13). However, this
could be achieved only in a minority of hypometabolic
children.
TC and LDL-C concentrations obtained in the
patients treated with L-T4 correlated well with the cor-
responding TSH levels (Figure 2). Significant associa-
tions with TSH were reported for TC and LDL-C by
other authors as well (3, 15) and have been variously
attributed to suboptimal therapy and/or an abnormal
setting of the T4 negative feedback control of pituitary
TSH secretion (16’18). Further investigations are ne-
eded to explain which of the two mechanisms caused
the persistence of elevated TSH values in some of the
L-T4-treated children included in this study.
In the oldest group (15.1’18 years), HDL-C was
significantly lower in the patients, but the patients/con-
trols differences were not significant in other age
groups. Conflicting results appeared in the literature
concerning HDL levels in hypothyroidism. Verdugo et
al. (7) found normal HDL-C values in hypothyroid wo-
men, Agdeppa et al. (11) reported decreased values in
hypothyroidism, whereas the increase of HDL-C con-
centration was observed in several studies (8’10). In
any case, the influence of thyroid hormone deficiency
on serum HDL-C levels is not so marked as the effect
on LDL-C and TC values. However, there is evidence
that the composition of HDL particles is altered in
hypothyroid state (4, 5). The effect is mediated thro-
ugh the regulation of CETP and HL genes expression
by thyroid hormones. Tan et al (5) have shown for the
first time that the concentration of HDL particles con-
taining only apo A-I (LpA-I) was increased in hypothy-
roidism. As LpA-I is more antiatherogenic than LpA-II
(19), its increase in hypothyroid individuals might part-
ly counteract the harmful effect of raised LDL-C.
Slightly higher TG concentrations were found in
patients than in healthy children, but only in some age
groups, whereas no significant differences were found
in the others (Table I). This is in agreement with the
findings of other authors: TG and VLDL levels in hy-
pothyroidism are normal or sometimes elevated (2),
because of decreased lipoprotein lipase activity and a
consequent slower rate of VLDL catabolism (20).
However, the extent of this effect is not always suffi-
cient to produce a statistically significant difference
between the TG values found in healthy and hypothy-
roid individuals, or before and after L-T4 treatment.
In conclusion, hypothyroidism caused a marked
increase in serum TC and LDL-C concentrations in the
population of children from Montenegro, reaching the
values associated with high risk of atherosclerosis.
Long-term L-T4 replacement therapy reversed this
effect, especially in normometabolic children and
those with lower THS values.
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LIPIDNI STATUS U DECE SA HIPOTIREOIDIZMOM: 
UTICAJ BOLESTI I SUPSTITUCIONE TERAPIJE LEVOTIROKSINOM
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Kratak sadr`aj: Hipotireoidizam je povezan sa dislipidemijom i pove}anim rizikom od ateroskleroze. Cilj
ovog rada je bio da se ispita uticaj bolesti i dugoro~ne supstitucione terapije levotiroksinom (L-T4) na lipidni sta-
tus dece sa hipotireoidizmom. Odre|ene su koncentracije ukupnog holesterola (TC), HDL-holesterola (HDL-C),
LDL-holesterola (LDL-C), triglicerida (TG) i tireostimuliraju}eg hormona (TSH) u uzorcima seruma sakupljenim
od 58 dece sa hipotireoidizmom (pre i posle terapije) i 100 zdrave dece. Hipotireoidizam je najvi{e uticao na vred-
nosti LDL-C i TC: kod pacijenata su na|ene prose~no 100% (LDL-C), odnosno 54% (TC) vi{e koncentracije nego
u kontrolnoj grupi. Ovo se sla`e sa poznatom ~injenicom da je katabolizam LDL ~estica u hipotireoidizmu
usporen. Vrednosti TG su bile ne{to vi{e (p<0,05), a HDL-C ni`e (p<0,02), ali samo u nekim starosnim grupa-
ma pacijenata. Dugoro~na supstituciona terapija imala je najizrazitiji uticaj na nivoe LDL-C i TC: vrednosti dobi-
jene kod pacijenata posle terapije bile su znatno ni`e nego pre terapije i nisu se zna~ajno razlikovale od koncen-
tracija dobijenih kod zdrave dece odgovaraju}e starosti. Zna~ajno ni`e vrednosti HDL-C i TG posle davanja L-T4
dobijene su jedino kod dece uzrasta od 10 do 15 godina. Sni`enje vrednosti TC i LDL-C pod uticajem L-T4 bilo
je izra`enije kod normometaboli~nih nego kod hipometaboli~nih pacijenata (p<0,01). Kod pacijenata pod te-
rapijom L-T4, dobijena je dobra korelacija izme|u nivoa TC, odnosno LDL-C pacijenata sa koncentracijom TSH
(r = 0,770 i 0,725, respektivno).
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